Patient Blood Management Market was valued at US $13.08 billion in 2021 and is projected to grow at 8.34% CAGR over the forecast period to reach US $21.14 billion by 2027. Patient Blood Management Market represented US $1.94 billion opportunity over 2019-2021 and estimated to create US $8.07 billion opportunity in 2027 over 2021.
Patient Blood Management from Consainsights analyses the Patient Blood Management Market in the Life Sciences industry over the forecast period to 2027.
Patient Blood Management research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.
Patient Blood Management segmentation includes Product, Component, End User, Region and Geography.
Based on the Product, the Patient Blood Management analysis covers Instruments, Accessories, Reagents and Kits, Software.
In Product segment, Instruments segment has highest cagr growth of 7.38%.
Based on the Component, the Patient Blood Management analysis covers Whole Blood & Red Blood Cells, Plasma.
In Component segment, Whole Blood & Red Blood Cells segment has highest cagr growth of 7.38%.
Based on the End User, the Patient Blood Management analysis covers Blood Banks, Hospitals, Diagnostic Clinics and & Pathology Labs.
In End User segment, Blood Banks segment has highest cagr growth of 7.38%.
Based on the Region, the Patient Blood Management analysis covers North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
In Region segment, North America segment has highest cagr growth of 7.38%.
Based on the region, the Patient Blood Management analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.
Key companies operating in the market include Haemonetics Corporation, Fresenius Se & Co. KGaA, Terumo Corporation, Immucor, Inc., B. Braun Melsungen AG, Macopharma, Biomérieux SA, Asahi Kasei Medical Co. Ltd. (A Subsidiary of Asahi Kasei Corporation), Kaneka Corporation, Bio-Rad Laboratories, Inc., Abbott Laboratories, Grifols, S.A., F. Hoffmann-La Roche LTD., Livanova PLC, Danaher Corporation, Other Companies and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.